Richard W Price Selected Research

AIDS Dementia Complex

6/2010	Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.
12/2009	Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
6/2007	Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
3/2007	Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial.
11/2005	Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
11/2005	Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection.
8/2005	Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients.
7/2004	Chemokine receptors, neural progenitor cells, and the AIDS dementia complex.
5/2004	The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations.
10/2002	HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Richard W Price Research Topics

Disease

33	Infections 01/2022 - 01/2004
32	HIV Infections (HIV Infection) 07/2022 - 10/2002
17	Inflammation (Inflammations) 01/2022 - 12/2006
12	Central Nervous System Infections (Central Nervous System Infection) 01/2022 - 03/2005
10	AIDS Dementia Complex 06/2010 - 10/2002
8	Brain Injuries (Brain Injury) 01/2014 - 05/2004
7	Acquired Immunodeficiency Syndrome (AIDS) 12/2019 - 04/2002
5	Opportunistic Infections (Opportunistic Infection) 07/2022 - 10/2002
5	Neuroinflammatory Diseases 01/2022 - 02/2013
5	Dementia (Dementias) 01/2022 - 01/2014
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 03/2007
4	Encephalitis (Encephalitis, Rasmussen) 01/2020 - 12/2004
4	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 12/2009
3	Disease Progression 01/2022 - 03/2012
3	Neurologic Manifestations (Neurological Manifestations) 12/2021 - 05/2004
3	COVID-19 12/2021 - 01/2020
3	Neurocognitive Disorders (Clerambault Syndrome) 01/2019 - 12/2011
3	Persistent Infection 01/2018 - 09/2011
3	Central Nervous System Diseases (CNS Diseases) 12/2013 - 12/2004
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 09/2012
2	Stroke (Strokes) 01/2017 - 07/2010
2	Viremia 01/2016 - 03/2005
2	Leukocytosis (Pleocytosis) 09/2012 - 08/2005
1	Atrophy 01/2022
1	Frontotemporal Dementia (Semantic Dementia) 01/2019
1	Lewy Body Disease (Lewy Body Dementia) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Ischemic Stroke 11/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2014
1	Lentivirus Infections 05/2011
1	Heart Failure 07/2010
1	Pulmonary Embolism 07/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 07/2010
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2010
1	Neoplasms (Cancer) 07/2010
1	Myocardial Infarction 07/2010
1	Peripheral Arterial Disease 07/2010
1	Liver Diseases (Liver Disease) 07/2010
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2010
1	Diabetes Mellitus 07/2010
1	Cryptococcal Meningitis 06/2010
1	Multiple Sclerosis 12/2009
1	Retroviridae Infections (Infection, Retrovirus) 11/2005
1	Brain Diseases (Brain Disorder) 09/2005
1	Leukoencephalopathies 12/2004

Drug/Important Bio-Agent (IBA)

27	RNA (Ribonucleic Acid)IBA 07/2022 - 05/2004
25	Biomarkers (Surrogate Marker)IBA 07/2022 - 03/2007
15	NeopterinIBA 01/2022 - 08/2005
12	Proteins (Proteins, Gene)FDA Link 07/2022 - 11/2005
4	Indicators and Reagents (Reagents)IBA 02/2020 - 08/2005
4	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 01/2019 - 06/2007
4	Serum AlbuminIBA 01/2017 - 09/2011
4	Pharmaceutical PreparationsIBA 02/2012 - 05/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2009
3	AlbuminsIBA 12/2021 - 09/2011
3	Amyloid beta-PeptidesIBA 06/2013 - 12/2009
3	Amyloid (Amyloid Fibrils)IBA 06/2013 - 12/2009
3	ChemokinesIBA 09/2011 - 03/2005
3	Antiviral Agents (Antivirals)IBA 05/2011 - 05/2004
3	Chemokine ReceptorsIBA 03/2005 - 06/2004
2	Immunoglobulin G (IgG)IBA 01/2022 - 12/2021
2	Peptides (Polypeptides)IBA 01/2014 - 03/2012
2	Biological ProductsIBA 12/2013 - 05/2011
2	ProteomeIBA 12/2013 - 03/2012
2	Interferon-gamma (Interferon, gamma)IBA 06/2013 - 11/2005
2	Raltegravir Potassium FDA Link 12/2011 - 09/2009
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 12/2004 - 05/2004
1	Immunoglobulin M (IgM)IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	LipopolysaccharidesIBA 01/2021
1	Glial Fibrillary Acidic ProteinIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 12/2019
1	NeurograninIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	CytokinesIBA 01/2019
1	LectinsIBA 01/2019
1	HIV AntibodiesIBA 01/2018
1	AntibodiesIBA 01/2018
1	Small Cytoplasmic RNAIBA 01/2018
1	B 31IBA 11/2017
1	CholesterolIBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	Viral RNAIBA 01/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2015
1	A-factor (Streptomyces)IBA 11/2014
1	neurofilament protein LIBA 01/2014
1	Protons (Proton)IBA 06/2013
1	immune RNA (I-RNA)IBA 03/2012
1	Tetracycline (Achromycin)FDA LinkGeneric 05/2011
1	Minocycline (Cyclops)FDA LinkGeneric 05/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2011
1	Neurofilament ProteinsIBA 08/2007
1	abacavir (Ziagen)FDA Link 03/2007
1	Chemotactic FactorsIBA 11/2005
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2004
1	HIV Core Protein p24IBA 12/2004
1	AntigensIBA 06/2004

Therapy/Procedure

22	Therapeutics 12/2019 - 04/2002
14	Highly Active Antiretroviral Therapy (HAART) 11/2018 - 04/2002
12	Art Therapy 01/2022 - 11/2005